humanitarian Archived signal

Human medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eiyzey, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eiyzey, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised
INCIDENT EVOLUTION

2 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.